CD44 and neoplasm: Regarding gene therapy strategies, complementary DNA (cDNA) vaccine to CD44 variant isoforms, but not CD44s, demonstrated decreased tumor growth, aggressiveness and metastasis in breast cancer xenografts (Wallach-Dayan et al., 2008).